Our impact so far

Immunoflourescence image Edinburgh University

Since 1956, you’ve helped us invest over £155 million (in today’s money) in MS research, supporting some fantastic breakthroughs.

From the development of new treatments, to investing in world-leading MS researchers, your support has had a significant impact and helped us move towards our vision of a world free from the effects of MS.

We’ve been here for people with MS for over 60 years. Here are some of the most significant milestones we’ve reached along the way…


 

  • 2007...

    We set the Edinburgh Centre for MS Research with generous support from the Volant Trust. The centre is co-led by Professor Charles ffrench-Constant and Professor Siddharthan Chandran.
  • 2012...

    Botox is licensed as a safe and effective treatment for overactive bladder in MS. We funded early research into the benefits of Botox for people with MS.
  • 2014...

    First positive clinical trial results for progressive MS are published. Simvastatin shows potential to slow or stop disability progression.
  • 2015...

    Research reveals the long term benefits of early treatment
  • 2016...

    Ocrelizumab slow progression of MS in large phase 3 trials and is now being considered for licensing. If it's successful, it will be the first licensed treatment for primary progressive MS.

What next...?

Our aim to stop MS. But we need to continue funding world-class research to help us get there.

There has never been a more crucial time for MS research in the UK. From breakthroughs in MS treatments, to figuring out what causes it — we’re getting close to stopping MS.

Little by little, step by step, your contributions can — and will — help us go all the way.

>> Donate today and we can stop MS together

The next research breakthrough is within reach

Donate now

What's new?